chartexchange

Novo Gets FDA Approval For First-Of-Its-Kind Weekly Growth Hormone Treatment For Children With Turner Syndrome

Stocktwits | Nov 20, 2026 1:06 PM EST

The approval was supported by Novo’s Phase 3 Real8 trial involving 105 children with Turner syndrome.

Read original article